Nuvation Bio (NUVB) Change in Cash (2020 - 2026)

Nuvation Bio (NUVB) has reported Change in Cash for 7 consecutive years, with -$38.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 415.77% year-over-year to -$38.7 million; the TTM figure through Mar 2026 stood at $77.4 million (up 474.84% YoY), while the FY2025 annual figure was $128.4 million, up 1953.35% from the prior year.
• Change in Cash slipped to -$38.7 million in Q1 2026 per NUVB's latest filing, from $65.2 million in the prior quarter.
• Across five years, Change in Cash topped out at $200.0 million in Q2 2025 and bottomed at -$149.1 million in Q3 2025.
• Historically, Change in Cash has averaged -$413647.1 across 5 years, with a median of -$3.9 million in 2022.
• On a YoY basis, Change in Cash climbed as much as 88985.78% in 2025 and fell as far as 3408.43% in 2025.
• Nuvation Bio's Change in Cash stood at -$37.6 million in 2022, then soared by 148.56% to $18.3 million in 2023, then slumped by 68.85% to $5.7 million in 2024, then surged by 1046.28% to $65.2 million in 2025, then slumped by 159.36% to -$38.7 million in 2026.
• Business Quant data shows NUVB's Change in Cash at -$38.7 million in Q1 2026, $65.2 million in Q4 2025, and -$149.1 million in Q3 2025.